Clinical trial Recruiting at 1 site Interventional Ages 19 to 79

Pharmacist-led opioid stewardship for adults with chronic non-cancer pain

Official title: Evaluation of an Opioid Stewardship Program in Non-Cancer Patients

Run by Korea University Guro Hospital · NCT07102446 · Data updated 2026-11-12

This program will test whether a pharmacist-led opioid stewardship program helps adults with chronic non-cancer pain reduce high-risk opioid prescriptions and improve their knowledge and attitudes about opioid use.

More Opioid Use trials

Quick facts

Study typeInterventional
Ages19 Years to 79 Years
SexAll
Enrollment70 (estimated)
SponsorKorea University Guro Hospital
Academic / other
Locations1 site (Seoul, Seoul)
StatusRecruiting
StartedJune 27, 2025
Main results expectedDecember 2025
Study endsJune 2026
Registry record updatedAugust 3, 2025
Trial IDNCT07102446 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19–79 with chronic non-cancer pain who received opioid prescriptions at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine & Rehabilitation at Korea University Guro Hospital and who can give informed consent.

Probably not a fit

Patients with active cancer, sickle cell disease, those receiving hospice or palliative care, pregnant patients, or individuals not receiving outpatient opioid prescriptions are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, non-randomized interventional program introduces a pharmacist-led Opioid Stewardship Program (OSP) for outpatient adults with chronic non-cancer pain at Korea University Guro Hospital. The OSP includes pharmacist review of opioid prescriptions, patient education, and tailored recommendations communicated to prescribing clinicians. Outcomes from the implementation period will be compared with a historical control to measure changes in the incidence of high-risk opioid prescribing and in patients' awareness, knowledge, and attitudes about opioid use. Eligible participants are adults aged 19–79 who received specified opioid prescriptions in the designated departments during the study window.

Why it matters

Potential benefit: If successful, the program could lower high-risk opioid prescribing and improve patient safety and understanding about opioid use.

How similar studies have gone: Previous pharmacist-led opioid stewardship and multidisciplinary interventions have shown reductions in high-risk prescribing and improved patient education, so this approach has supportive precedent in the literature.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Outpatients at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine \& Rehabilitation of the study site who received a prescription for opioid analgesics (oral, transdermal, sublingual, or buccal formulations containing oxycodone, fentanyl, tapentadol, hydrocodone, or morphine) due to chronic non-cancer pain during the study evaluation period (from IRB approval date to September 30, 2025)
* Adults aged ≥19 years and \<80 years
* Patients who voluntarily signed a written informed consent form after receiving a full explanation of the study and understanding its purpose

Exclusion Criteria:

* Patients with active cancer
* Patients diagnosed with sickle cell disease
* Patients diagnosed with a life-limiting illness eligible for hospice or palliative care as defined in Article 2 of the 'ACT ON HOSPICE AND PALLIATIVE CARE AND DECISIONS ON LIFE-SUSTAINING TREATMENT FOR PATIENTS AT THE END OF LIFE'
* Pregnant patients
* Patients who were prescribed opioid analgesics within the past month for postoperative pain management
* Patients who were prescribed opioid analgesics within the past month for newly developed pain
* Patients with communication difficulties
* Patients who were prescribed buprenorphine for the treatment of opioid use disorder
* Patients who are deemed inappropriate for study participation at the discretion of the investigator

Where it's running

  • Korea University Guro Hospital
    Seoul, Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.